Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 9, 2008
Patent Application Number
09911703
Date Filed
July 25, 2001
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are chimeric, immunologically active, isolated, and radiolabeled antibodies directed against the CD20 antigen. The antibodies are useful for treating and diagnosing B cell disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.